Neurosyphilis in HIV-infected patients

Cover Page

Abstract


A review article is addressed the issue of the diagnosis and treatment of neurosyphilis that is developing against the background of HIV-infection. HIV-infected patients are at higher risk of neurologic, ocular and auricular manifestation of syphilis as well as treatment failures and relapses. Diagnosis of neurosyphilis in HIV-positive patients is complicated because both infections cause similar changes in the cerebrospinal fluid (CSF). The effectiveness of neurosyphilis treatment in patients with HIV co-infection is difficult to estimate, since the normalization of their CSF goes slower comparing to HIV-negatives. The increase in incidence of syphilis and HIV co-infection is anticipated in the coming years. This necessitates a comprehensive study of the problem and requires the development of new approaches to neurosyphilis diagnosis and treatment in co-infected patients.

T. V. Krasnoselskikh

First Pavlov State Medical University

Author for correspondence.
Email: tatiana.krasnoselskikh@gmail.com

Russian Federation

E. V. Sokolovskiy

First Pavlov State Medical University

Email: noemail@neicon.ru

Russian Federation

  1. Centers for Disease Control and Prevention. The national plan to eliminate syphilis from the United States. Atlanta, Georgia: U.S. Department of Health and Human Services 1999; 1-84.
  2. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2011. Atlanta, Georgia: U.S. Department of Health and Human Services 2012; 1-156.
  3. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 18-30.
  4. Wilcox R.D. The challenge of neurosyphilis in HIV. HIV Clin 2009; 21 (3): 5-6.
  5. Marra C.M., Maxwell C.L., Collier A.C. et al. Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy. BMC Infect Dis 2007; 7: 37.
  6. Centers for Disease Control and Prevention. Symptomatic early neurosyphilis among HIV-positive men who have sex with men - four cities, United States, January 2002-June 2004. MMWR Morb Mortal Wkly Rep 2007; 5: 625-628.
  7. Zetola N.M., Klausner J.D. Syphilis and HIV infection: an update. Clin Infect Dis 2007; 44 (9): 1222-1228.
  8. Ghanem K.G., Moore R.D., Rompalo A.M. et al. Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS 2008; 22 (10): 1145-1151.
  9. Schöfer H., Imhof M., Thoma-Greber E. et al. Active syphilis in HIV infection: a multicenter retrospective survey. The German AIDS Study Group (GASG). Genitourin Med 1996; 72 (3): 176-181.
  10. Kinghorn G.R. Infectious Diseases, 2nd Ed. Mosby: London, UK 2004, pp. 807-816.
  11. Chan D.J. Syphilis and HIV: when is lumbar puncture indicated? Curr HIV Res 2005; 3 (1): 95-98.
  12. Dumaresq J., Langevin S., Gagnon S. et al. Clinical prediction and diagnosis of neurosyphilis in HIV-infected patients with early syphilis. J Clin Microbiol 2013; 51 (12): 4060-4066.
  13. Lukehart S.A., Hook E.W. 3rd, Baker-Zander S.A. et al. Invasion of the Central Nervous System by Treponema pallidum: Implications for Diagnosis and Treatment. Ann. Intern. Med 1988; 109 (11): 855-862.
  14. Malone J.L., Wallace M.R., Hendrick B.B. et al. Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapy. Am J Med 1995; 99 (1): 55-63.
  15. ВИЧ-инфекция в Российской Федерации в 2013 г. Федеральный научно-методический центр по профилактике и борьбе со СПИДом [офиц. сайт]. Режим доступа: http://www.hivrussia.org/news/index.shtml#43
  16. Информационные бюллетени. Федеральный научно-методический центр по профилактике и борьбе со СПИДом [офиц. сайт]. Режим доступа: http://www.hivrussia.org/stat/bulletin.shtml
  17. Национальный доклад Российской Федерации о ходе выполнения Декларации о приверженности делу борьбы с ВИЧ/СПИДом, принятой в ходе 26-й специальной сессии Генеральной Ассамблеи ООН, июнь 2001 г. Отчетный период: январь 2006 г. - декабрь 2007 г. М., 2008. 51
  18. Bekker L.G., Beyrer C., Quinn T.C. Behavioral and biomedical combination strategies for HIV prevention. Cold Spring Harb Perspect Med 2012; 2 (8). pii: a007435.
  19. Mishra S.R., Khanal V. Sexual behaviors among men who have sex with men: a quantitative cross sectional study in Kathmandu Valley, Nepal. HIV AIDS (Auckl) 2013; 5: 81-88.
  20. Кубанова А.А., Мелехина Л.Е., Кубанов А.А., Богданова Е.В. Ресурсы и деятельность медицинских организаций дерматовенерологического профиля в Российской Федерации в 2013 году. Вестн. дерматол. венерол., 2014; (3): 16-36
  21. Ресурсы и деятельность медицинских организаций дерматовенерологического профиля. Заболеваемость инфекциями, передаваемыми половым путем, заразными кожными болезнями и болезнями кожи (статистические материалы). М, 2014; 237
  22. Mohr J.A., Griffiths W., Jackson R. et al. Neurosyphilis and penicillin levels in cerebrospinal fluid. JAMA 1976; 236 (19): 2208-2209.
  23. Dunlop E.M., Al-Egaily S.S., Houang E.T. Penicillin levels in blood and CSF achieved by treatment of syphilis. JAMA 1979; 241 (23): 2538-2540.
  24. Polnikorn N., Witoonpanich R., Vorachit M. et al. Penicillin concentrations in cerebrospinal fluid after different treatment regimens for syphilis. Br J Vener Dis 1980; 56 (6): 363-367.
  25. Tramont E.C. Treponema pallidum (Syphilis). In: Mandell G.L., Bennett J.E., Dolin R. (eds). Principles and Practice of Infectious Diseases (7th ed). Churchill Livingstone: Philadelphia, PA 2009; 3035-3053.
  26. Tramont E.C. Persistence of Treponema pallidum following penicillin G therapy - report of two cases. JAMA 1976; 236 (19): 2206-2207.
  27. Greene B.M., Miller N.R., Bynum T.E. Failure of penicillin G benzathine in the treatment of neurosyphilis. Arch Intern Med 1980; 140 (8): 1117-1118.
  28. Johns D.R., Tierney M., Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med 1987; 316 (25): 1569-1572.
  29. Berry C.D., Hooton T.M., Collier A.C. et al. Neurological relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987; 316 (25): 1587-1589.
  30. Musher D.M. Syphilis, neurosyphilis, penicillin, and AIDS. J Infect Dis 1991; 163 (6): 1201-1216.
  31. Taylor M.M., Aynalem G., Olea L.M. et al. A consequence of the syphilis epidemic among men who have sex with men (MSM): neurosyphilis in Los Angeles, 2001-2004. Sex Transm Dis 2008; 35 (5): 430-434.
  32. Singh A.E., Romanowski B. Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 1999; 12 (2): 187-209.
  33. Ghanem K.G., Moore R.D., Rompalo A.M. et al. Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms. Clin Infect Dis 2009; 48 (6): 816-821.
  34. Marra C.M., Maxwell C.L., Smith S.L. et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004; 189 (3): 369-376.
  35. Poliseli R., Vidal J.E., Penalva De Oliveira A.C. et al. Neurosyphilis in HIV-infected patients: clinical manifestations, serum venereal disease research laboratory titers, and associated factors to symptomatic neurosyphilis. Sex Transm Dis 2008; 35 (5): 425-429.
  36. Sparling P.F., Swartz M.N., Musher D.M., Healy B.P. Clinical Manifestations of Syphilis. In: Holmes K.K., Sparling P.F., Stamm W.E., Piot P., Wasserheit J., Corey L., Cohen M.S., Watts D.H. (eds). Sexually Transmitted Diseases (4th ed). McGraw Medical: New York City, NY 2008; 661-684.
  37. STD Surveillance Case Definitions. In: Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2012. U.S. Department of Health and Human Services: Atlanta, Georgia 2014; pp. 140-147.
  38. Sparling P.F. Diagnosis of Neurosyphilis: New Tools. Sex Transm Dis 2010; 37 (5): 288-289.
  39. Janier M., Hegyi V., Dupin N. et al. 2014 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol 2014; Oct 27. doi: 10.1111/ jdv.12734. [Epub ahead of print].
  40. Federal guidelines for the management of patients with syphilis. Moscow, 2013; 40. [Федеральные клинические рекомендации по ведению больных сифилисом. М, 2013; 40.]
  41. Castro R., Prieto E.S., da Luz Martins Pereira F. Nontreponemal tests in the diagnosis of neurosyphilis: an evaluation of the Venereal Disease Research Laboratory (VDRL) and the Rapid Plasma Reagin (RPR) tests. J Clin Lab Anal 2008; 22 (4): 257-261.
  42. Eaton M. Syphilis and HIV: Old and New Foes Aligned Against Us. Curr Infect Dis Rep 2009; 11 (2): 157-162.
  43. Hart G. Syphilis tests in diagnostic and therapeutic decision making. Ann Intern Med 1986; 104 (3): 368-376.
  44. Prange H.W., Moskophidis M., Schipper H.I., Müller F. Relationship between neurological features and intrathecal synthesis of IgG antibodies to Treponema pallidum in untreated and treated human neurosyphilis. J Neurol 1983; 230 (4): 241-252.
  45. MacLean S., Luger A. Finding neurosyphylis without the Venereal Disease Research Laboratory Test. Sex Transm Dis 1996; 23 (5): 392-394.
  46. Davis L.E., Schmitt J.W. Clinical significance of cerebrospinal fluid tests for neurosyphilis. Ann Neurol 1989; 25 (1): 50-55.
  47. van Eijk R.V.W., Wolters E.Ch., Tutuarima J.A. et al. Effect of early and late syphilis on central nervous system: cerebrospinal fluid changes and neurological deficit. Genitourin Med 1987; 63 (2): 77-82.
  48. Marra C.M., Tantalo L.C., Maxwell C.L. et al. Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals. Neurology 2004; 63 (1): 85-88.
  49. Marshall D.W., Brey R.L., Cahill W.T. et al. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 1988; 45 (9): 954-958.
  50. Libois A., De Wit S., Poll B. et al. HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis 2007; 34 (3): 141-144.
  51. Wang Y.J., Chi C.Y., Chou C.H. et al. Syphilis and neurosyphilis in human immunodeficiency virus-infected patients: a retrospective study at a teaching hospital in Taiwan. J Microbiol Immunol Infect 2012; 45 (5): 337-342.
  52. Farhi D., Benhaddou N., Grange P. et al. Clinical and serologic baseline and follow-up features of syphilis according to HIV status in the post-HAART era. Medicine 2009; 88 (6): 331-340.
  53. Rompalo A.M., Joesoef M.R., O’Donnell J.A. et al. Clinical manifestations of early syphilis by HIV status and gender: results of the syphilis and HIV study. Sex Transm Dis 2001; 28 (3): 158-165.
  54. Walter T., Lebouche B., Maiher P. et al. Symptomatic relapse of neurologic syphilis after benzathine penicillin G therapy for primary or secondary syphilis in HIV-infected patients. Clin Infect Dis 2006; 44 (1): 787-790.
  55. Workowski K.A., Berman S. Sexually transmitted diseases treatment guidelines, 20010. MMWR Recommendations and Reports 2010; 59 (RR-12).
  56. Marra C.M., Boutin P., McArthur J.C. et al. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis 2000; 30 (3): 540-544.
  57. Dowell M.E., Ross P.G., Musler D.M. et al. Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with HIV. Am J Med 1992; 93 (5): 481-488.
  58. Marra C.M., Boutin P., McArthur J.C. et al. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis 2000; 30 (3): 540-544.
  59. Morrison E., Harrison S., Tramont E.C. Oral amoxicillin, an alternative treatment of neurosyphilis. Genitourin Med 1985; 61 (6): 359-362.
  60. Yim C.W., Flynn N.M., Fitzgerald FT. Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis. Antimicrob Agents Chemother 1985; 28 (2): 347-348.
  61. Marra C.M., Maxwell C.L., Tantalo L. et al. Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter? Clin Infect Dis 2004; 38: 1001-1006.
  62. Marra C.M. Neurosyphilis. In: Scheld W.M., Whitley R.J., Marra C.M. (eds) Infectious Diseases of central Nervous System. Wolters Kluwer Health: Philadelphia, PA 2014; chapter 38.
  63. Gordon S.M., Eaton M.E., George R. et al. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med 1994; 331 (22): 1469- 1473.
  64. Marra C.M., Longstreth W.T. Jr., Maxwell C.L., Lukehart S.A. Resolution of serum and cerebrospinal fluid abnormalities after treatment of neuro-syphilis: influence of concomitant human immunodeficiency virus infection. Sex Transm Dis 1996; 23 (3): 184-189.

Views

Abstract - 257

PDF (Russian) - 48

Refbacks

  • There are currently no refbacks.

Copyright (c)



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies